ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of …

ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of …

ESSA Pharma is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of castration-resistant prostate cancer ("CRPC") in patients whose disease is progressing despite treatment with current …

(Visited 1 times, 1 visits today)
3
Like
Save

Comments

Comments are disabled for this post.